Stem Cell Therapy in Treating Epilepsy

Epilepsy is a common disabling chronic neurological disorder characterized by an enduring propensity for the generation of seizures that result from abnormal hypersynchronous firing of neurons in the brain. Over 20–30% of epilepsy patients fail to achieve seizure control or soon become resistant to...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 16; p. 934507
Main Authors Chang, Bao-Luen, Chang, Kuo-Hsuan
Format Journal Article
LanguageEnglish
Published Lausanne Frontiers Research Foundation 27.06.2022
Frontiers Media S.A
Subjects
Online AccessGet full text
ISSN1662-453X
1662-4548
1662-453X
DOI10.3389/fnins.2022.934507

Cover

More Information
Summary:Epilepsy is a common disabling chronic neurological disorder characterized by an enduring propensity for the generation of seizures that result from abnormal hypersynchronous firing of neurons in the brain. Over 20–30% of epilepsy patients fail to achieve seizure control or soon become resistant to currently available therapies. Prolonged seizures or uncontrolled chronic seizures would give rise to neuronal damage or death, astrocyte activation, reactive oxygen species production, and mitochondrial dysfunction. Stem cell therapy is potentially a promising novel therapeutic strategy for epilepsy. The regenerative properties of stem cell-based treatment provide an attractive approach for long-term seizure control, particularly in drug-resistant epilepsy. Embryonic stem cells (ESCs), mesenchymal stem cells (MSCs), neural stem cells (NSCs), induced pluripotent stem cells (iPSCs), and adipose-derived regenerative cells (ADRCs) are capable of differentiating into specialized cell types has been applied for epilepsy treatment in preclinical animal research and clinical trials. In this review, we focused on the advances in stem cell therapy for epilepsies. The goals of stem cell transplantation, its mechanisms underlying graft effects, the types of grafts, and their therapeutic effects were discussed. The cell and animal models used for investigating stem cell technology in epilepsy treatment were summarized.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience
Reviewed by: Stephanie Schorge, University College London, United Kingdom
Edited by: Yu-Chen Hu, National Tsing Hua University, Taiwan
ISSN:1662-453X
1662-4548
1662-453X
DOI:10.3389/fnins.2022.934507